Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Direct Oral Anticoagulants (DOACs)
- Target
- DOACs
- Molecular classification
- Pharmacological Class
01
Overview
Direct oral anticoagulants (DOACs) are a class of medications designed to prevent and treat blood clots by directly inhibiting specific proteins involved in the coagulation cascade, specifically Factor Xa or Thrombin (Factor IIa). They offer advantages over traditional anticoagulants like warfarin, including rapid onset, predictable pharmacokinetics, and fewer drug and food interactions. Key considerations include bleeding risk, the limited availability of reversal agents for some DOACs, and the need for dose adjustments in patients with renal impairment.
- Other names
- Non-vitamin K antagonist oral anticoagulants (NOACs)Target-specific oral anticoagulants (TSOACs)
02
Mechanism of action
Direct inhibition of Factor Xa or Thrombin (Factor IIa)
03
Biological functions
AnticoagulationThromboprophylaxisTreatment of thromboembolic disorders
04
Disease associations
Venous thromboembolism (VTE)Atrial fibrillationStrokeDeep vein thrombosis (DVT)Pulmonary embolism (PE)
05
Safety considerations
Bleeding riskLack of specific reversal agents (except dabigatran)Renal impairment requiring dose adjustment
06
Interacting drugs
Rivaroxaban
5 more in the full profile.
Beyond the preview
Go deeper on Direct Oral Anticoagulants (DOACs).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Direct Oral Anticoagulants (DOACs).